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ABSTRACT  Class I transplantation  antigens  form  complexes  with a virus  protein  encoded  in 
the early region E3 of the adenovirus-2 genome. The interaction  between this viral  glycopro- 
tein,  E19, and  nascent  human class I antigens has been examined  by microinjecting  purified 
mRNA into Xenopus laevis oocytes.  Both  E19 and the two class I antigen subunits, the heavy 
chain and fl2-microglobulin (fl2M), were efficiently translated. The heavy chains did not become 
terminally glycosylated, as monitored by endoglycosidase H digestion, and were not expressed 
on the oocyte surface  unless they were associated  with/3~M. The E19 protein did not become 
terminally glycosylated, and we failed to detect this viral  protein on the surface of the oocytes. 
Co-translation  of heavy chain and  E19 mRNA demonstrated  that the two proteins associate 
intracellularly.  However,  neither  protein  appeared  to  be  transported  to  the  trans-Golgi 
compartment. Similar observations were made in adenovirus-infected  HeLa cells. Heavy chains 
bound to ~2M became terminally glycosylated in oocytes in the presence of low concentrations 
of E19. At high concentrations of the viral  protein, no carbohydrate modifications and no cell 
surface  expression of class I antigens were apparent. Thus,/~2M and E19 have opposite effects 
on the intracellular transport of the heavy chains.  These  data  suggest that adenovirus-2  may 
impede the cell surface  expression of class I antigens  to escape  immune surveillance. 
Major histocompatibility antigens regulate various cell-cell 
interactions of importance to the immune system (1). This is 
exemplified by the recognition of viral antigens by cytotoxic 
T-lymphocytes, which only occurs provided that the foreign 
molecules are  in juxtaposition  to  major histocompatibility 
complex class I antigens (2). Whether this requirement signi- 
fies that the two types of molecules actually are in physical 
contact is as yet unresolved (3, 4). 
It has been shown  that  class I  antigens interact with  an 
adenovirus-2 protein (3-8).  This viral protein is one of the 
few that associate with  class I  antigens to form complexes 
stable enough to allow for their isolation (5,  7). The adeno- 
protein is encoded in the early region E3 of the viral genome 
(9-11).  Due  to its origin  and  the  molecular weight of the 
polypeptide portion,  which  is -19,000  (12),  this protein  is 
called El9. However, El9 contains two Asn-linked carbohy- 
drate moieties (13) so the glycosylated protein has an apparent 
molecular weight of -25,000. In vivo it exists predominantly 
as a dimer. 
Class I antigen-E 19 complexes are held together by non- 
covalent interactions only, but the precise nature of the asso- 
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ciation is not understood.  However, preliminary studies in- 
dicate that it is the glycosylated, membrane-spanning heavy 
chain of the class I antigens that binds El9 (7). 
Complex formation between class I antigens and El9 may 
be initiated in the endoplasmic reticulum, since all polypep- 
tides of the complex are manufactured by membrane-bound 
ribosomes (14).  Such an association may affect the intracel- 
lular transport of individual constituents of the complex. This 
is particularly likely as regards the class I antigens since the 
interaction  between  fl2-microglobulin  (B2M)  ~  and  heavy 
chains regulates the intracellular transport of these molecules 
(15,  16). We  have  examined  the  biogenesis  of the  class  I 
antigen-El9  complexes by  microinjecting relevant  mRNA 
into  Xenopus  laevis  oocytes,  which  previously  have  been 
shown  to faithfully reproduce the  intracellular transport of 
class I antigens in  mammalian cells (17).  In this paper, we 
demonstrate that  in  oocytes the  El9  protein  abrogates the 
intracellular transport of class I antigens. 
~Abbreviations  used  in  this  paper.  /32M, ~2-microglobulin; DME, 
Dulbecco's modified Eagle's medium; Endo H, endoglycosidase  H. 
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Antisera:  A rabbit antiserum  against human class I antigens was ren- 
dered  specific for the  heavy  chain  by  extensive  absorptions  on  a  column 
containing BzM (18). A previously described rat monoclonal antibody against 
~2M was used (7). A mouse monoclonal  antibody against El9 (a kind gift of 
Mats Andersson and Carmen Fernandez, manuscript  in preparation) was also 
used. 
Isolation of mRNA and Cell-free  Translation:  Human class I 
antigen  heavy chain  mRNA and /3:M mRNA were separately isolated from 
Raji cells. El9 mRNA was obtained from HeLa cells 6-7 h postinfection with 
10,000 adeno-2 virions per cell. A detailed description has been published (14). 
Briefly, microsomes were isolated from lysed cells, and the microsomal RNA 
was  extracted  by  phenol/chloruform/isoamylalcohol  (49:49:2,  vol/vol/vol). 
Poly A-containing mRNA was isolated by two cycles of oligo dT column 
chromatography and then size fractionated by sucrose-density gradient centrif- 
ugation. The distribution in the sucrose gradient fractions of mRNA coding for 
the class I antigen subunits and the El9 protein, respectively, was monitored 
by  subjecting aliquots  of each  fraction  of the various  gradients  to cell-free 
translation. A previously described rabbit reticulocyte lysate translation system 
containing dog pancreas microsomes was used (19). 
Fractions containing  mRNA coding for only one of the polypeptides were 
used individually  or in various combinations  for the microinjection  experi- 
ments. 
Purification  of  mRNA  by  Hybridization  Selection:  The 
EcoRI-D  fragment of the  adenovirns-2 genome, encompassing the sequence 
coding for the El9 protein (12), was cloned into pBR322. Plasmid DNA was 
isolated and immobilized onto nitrocellulose filters as described (20). To one- 
half of the filter, 2.5 ug of mRNA was hybridized according to the protocol of 
Ricciardi et al. (21). mRNA, eluted  from the filter after extensive washings, 
was used for microinjection into Xenopus oocytes. 
The purity of the hybridization-selected El9 mRNA fraction was assessed 
by microinjecting aliquots  into  oocytes, which then were labeled with  [asS]- 
methionine (Amersham Corp., Amersham, Buckinghamshire, England) for 24 
h. The total glycoprotein fraction of the labeled oocytes was analyzed by SDS 
PAGE. Noninjected,  labeled oocytes served as the control. By this procedure, 
it was established that  the purified El9 mRNA fraction gave rise to a single 
extra component with an apparent  molecular weight of 25,000, as compared 
with noninjected oocytes (not shown). 
Microinjection  into Oocytes:  Large  Xenopus laevis females were 
injected with  1,000 IU of human chorionic  gonadotropin  (Sigma Chemical 
Co., St. Louis, MO) 1-2 wk before they were killed and the oocytes isolated. 
In a typical experiment, 30-40 oocytes were microinjected with 50 nl each of 
a mRNA fraction or combinations of mRNA fractions containing 200-500 ug 
mRNA/ml of distilled water. If not otherwise stated, the oocytes were then 
incubated in 150 ul of BarFs medium (22) containing 0.2 mCi [3SS]methionine 
at  19"C for 20-24  h. After the labeling period, the oocytes were homogenized 
in 0.5 ml of ice-cold 20 mM Tris-Cl buffer, pH 8.0, 1% Triton X-100, 0.15 M 
NaCl,  and  1%  Trasylol  (Bayer AG,  Leverkusen, FRG) in a  small  Dounce 
homogenizer,  and  the  suspension  was centrifuged  for  15  rain  at  10,(300 g. 
Glycoproteins in the supernatants  were usually enriched  by chromatography 
on Lens Culinaris hemagglutinin-Sepharose 4B columns (23). Bound glycopro- 
reins were desorbed by the addition of 10% a-methylmannoside  to the eluant, 
which was identical to the lysis buffer, and subjected to indirect immunopre- 
cipitation. 
Oocyte Surface Expression of Translation Products:  To as- 
sess the expression on the oocyte surface of  translation products from microin- 
jected mRNA, a modification of a previously described method was used (24). 
Injected oocytes, incubated  with  [aSSlmethionine for 20-24  h, were washed 
with Bait's medium and defolliculated by incubation  for 50 rain at 22-24"C 
with 2 mg/ml of collagenase (Worthington  Biochemical Corp., Freehold, N  J) 
in 0. l M phosphate buffer, pH 7.6. After extensive washing in Barfs medium 
and a final wash with buffer B (50 mM phosphate buffer pH 7.5, 80 mM NaCI, 
0.5% bovine serum albumin),  aliquots of the oocyte fraction were separately 
incubated  in the cold for 60 rain with dilutions, ranging from  l:10 to 1:20, of 
the various antisera made up in buffer B. The oocytes were washed five times 
with buffer B and then  homogenized as described above. Immediately after 
homogenization, the material was centrifuged for 15 rain at  10,000 g, and 50 
ul of  a 20% suspension of formalin-fixed Staphylococcus aureus Cowan I strain 
bacteria was added to the supernatant.  After 30 min, the bacteria were exten- 
sively washed according to a standard protocol (16) and the adsorbed material 
was subjected  to  electrophoresis.  After  the  first  immunoprecipitation,  the 
resulting supernatant  was subjected to indirect immunoprecipitation.  Material 
recovered in  this  second  immunoprecipitation  was presumed  to be  located 
inside the cell. 
Cell Culture Growth,  Adenovirus-2  Infection,  and Radio- 
active  Labeling:  Monolayer cultures of HeLa cells were grown in Dul- 
becco's modified Eagle's medium (DME, Gibco  Laboratories, Grand Island, 
NY) containing 2.5% normal calf serum, 2.5% fetal calf serum,  100 U/ml of 
penicillin, and  100 ~g/ml of streptomycin in flat-bottom tissue culture flasks 
(Costar, Cambridge, MA). Infections of HeLa  cells by human adenovirus-2 
were carried out with ~l  x  104 virions per cell using 2 x  l0  ~ cells growing in 
a 25-cm  2 flat-bottom  tissue culture flask. The virus particles were added  to 
subconfluent cell monolayers in serum-free medium. After l h, normal serum- 
containing  medium  was added, and the cells were incubated  further for 3 h 
before they were labeled with [3SS]methionine. 
Cells were washed once  with  phosphate-buffered  saline (pH  7.4) before 
addition  of methionine-free  DME supplemented  with 4 mM glutamine,  5% 
dialyzed fetal calf serum, and 0.25 mCi [3~S]methionine. Pulse-chase experi- 
ments were performed by labeling the cells for  l0 rain, and then  cells were 
either solubilized at 0*C or washed and further incubated in the normal culture 
medium  containing  20  mM  of unlabeled  methionine.  The incubation  was 
terminated by lysing the cells with 0.02 M Tris-HCI buffer (pH 7.5) containing 
0.15 M NAG1, l% Triton  X-100, and 1% Trasylol. After 30 rain at 0*C, cell 
debris  was removed  by centrifugation  at  10.000 g  for  15  min at  4"C. The 
supernatants were enriched for glycoproteins on Lens Culinaris hemagglutinin- 
Sepharose 4B columns (23), and the eluted material was subjected to indirect 
immunoprecipitation. 
Immunoprecipitations and Electrophoretic  Analyses:  In- 
direct  immunoprecipitations were done according to a standard protocol (16). 
lmmunoprecipitated  proteins  were separated  by gradient  slab  SDS  PAGE, 
essentially as described by Blobel and Dobberstein (25). Ovalbumin (molecular 
weight 46.000), carbonicanhydrase  (molecular weight 30,000), and lysozyme 
(molecular weight 14,300) were always run in parallel as marker proteins. Gels 
were fixed in 10% triehloroaeetic acid for 15 min at 4"C, treated with Enhancer 
(New England Nuclear, Boston, MA) for 60 min, and finally soaked in water 
containing  1% glycerol for 15-30 min. After drying, fluorography of the gels 
was performed as described (26). Kodak XAR film was used throughout.  For 
quantitation  of protein  bands,  fluorographs were scanned  using a Beckman 
Densitometer (Beckman Instruments, Inc., Palo Alto, CA). 
In accordance with previous studies 06,  17), terminally glycosytated heavy 
chains have been assigned an apparent  molecular weight of 45,000, whereas 
core  glycosylated and  endoglycosidase H  (Endo  H)--digested heavy  chains 
display apparent  molecular  weights of 43,000 and 41,000,  respectively. The 
El9  protein  exhibits  an  apparent  molecular  weight of 25,000  when  fully 
glycosylated, but is called El9 to adhere to the nomenclature  used earlier (4- 
8). 
Enzyme  Digestion:  Asn-linked core-sugar  moieties  were removed 
from immunoprecipitated  proteins using Endo H (Seikagaku Kogyoco, Tokyo, 
Japan) according to the protocols previously described (16). 
RESULTS 
Translation of El9 mRNA in the Absence and 
Presence of rnRNA of Class I Antigen Subunits 
To examine the translation and processing of the adenovi- 
rus El9  protein, Xenopus oocytes were  microinjected with 
mRNA encoding that protein. The oocytes were labeled with 
[3SS]methionine  for  1 h  and after various periods of chase, 
accomplished in the presence of 20 mM methionine, samples 
were withdrawn and glycoproteins were isolated and subjected 
to  indirect immunoprecipitation  using a  monoclonal anti- 
body against the E 19 protein. The immunoprecipitates were 
then analyzed by SDS PAGE.  After the labeling period, the 
El9 protein gave rise to a single electrophoretic band (Fig.  1, 
lane A). After a  chase period of 3  h, the major El9  band 
displayed a slightly increased electrophoretic mobility, and an 
additional, lower molecular weight band emerged (Fig. 1, lane 
B). After chase periods of 8 and 24 h (Fig.  l, lanes C and D), 
respectively,  the same two bands were apparent as after 3 h 
of chase. The El9 protein apparently became degraded con- 
siderably during the chase period. Thus, only a minor fraction 
of the radioactivity present in the E 19 band at the end of the 
labeling period remained immunoprecipitable throughout the 
entire chase period (compare lane D with lane A of Fig.  1). 
5EVERINSSON  AND  PETERSON  El9 Inhibits Transport  of Class I Antigens  541 FIGURE  1  Biosynthesis of the  E19 protein in oocytes in the absence and presence of class  I transplantation antigens. Oocytes 
were microinjected with a fraction enriched for E19 mRNA alone (lanes A-D) and combined with fractions enriched for heavy 
chain and B~M mRNA {lanes/:-L). The oocytes were labeled with [35S]methionine for 1 h, washed, and chased in the presence 
of 20  mM methionine for various periods of time. Samples were withdrawn, glycoproteins were isolated and precipitated with 
an anti  E19 monoclonal antibody (lanes A-H) or with an anti-heavy chain serum (lanes  I-L).  Samples withdrawn at the end of 
the labeling period are shown in lanes A, E, and I; after 3 h of chase in lanes B, F, and J; after 8 h of chase in lanes C, G, and K; 
and after 24 h of chase in lanes D, H, and L. The figures denote apparent molecular weights in kilodaltons. 
To examine whether mRNA encoding class I antigen sub- 
units would affect the translation and processing of the El9 
protein,  mRNA  encoding  the  El9,  class  I  antigen  heavy 
chains, and/32M were mixed before injection into the oocytes. 
The electrophoretic analyses are summarized in Fig.  1 (lanes 
E-L). It can be seen that in the presence of class I antigens, 
the El9 protein bands behaved qualitatively identical to the 
translation products obtained in the absence of class I antigens 
(compare lanes A-D with lanes E-H of Fig.  1). However, the 
shift toward El9 species with enhanced electrophoretic mo- 
bilities was  more pronounced  in  the  presence than  in  the 
absence of class I antigens. Furthermore, the degradation of 
the  El9  protein seemed to  increase by the  presence of the 
class I antigens, which themselves, as revealed by the immu- 
noprecipitated  heavy  chains,  were  only  slowly  eliminated 
during the chase period (Fig.  1, lanes l-L). In any event, these 
data demonstrate that the E 19 protein is efficiently translated 
by Xenopus oocytes also in the presence of class  I antigens. 
The two  new species of El9  that  appear during  the  chase 
period  are fully consistent with the  appearance of the  El9 
protein in mammalian cells after adenovirus infection. Since 
the El9 protein contains two Asn-linked carbohydrate moie- 
ties (13), the novel forms of the protein may represent mole- 
cules whose carbohydrate moieties are in the process of being 
trimmed. In the presence of class  I antigens, the conversion 
of El9  to the  apparently lower molecular weight  forms is 
more complete than in the absence of transplantation anti- 
gens. 
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Effect of E19 on the Terminal Glycosylation of 
Class I Antigen Heavy Chains 
In the previous experiments, neither E 19 nor class I antigen 
heavy chains displayed increased apparent molecular weights 
during  the  chase  period.  Thus,  no  evidence  for  terminal 
glycosylation of either protein was obtained. To directly ad- 
dress this issue, we examined whether E 19 and class I antigens, 
separately and together, reach the trans-Golefi compartment. 
This was accomplished by monitoring the susceptibility of the 
carbohydrate  moieties of the  two  proteins to  digestion  by 
Endo  H.  This enzyme digests  core sugar moieties but  not 
terminally glycosylated oligosaccharides (27). 
Oocytes were  injected  with  class  I  antigen  heavy chain 
mRNA alone or together with #2M  mRNA.  The  microin- 
jected oocytes were labeled for 26 h, and glycoproteins were 
isolated and subjected to indirect immunoprecipitation with 
use of an anti-heavy chain serum. Part of the immunoprecip- 
itates were treated with Endo H  before SDS PAGE analysis. 
Fig. 2 (lanes A and B) shows that class I antigen heavy chain 
mRNA  was  translated  into  a  single  electrophoretic  heavy 
chain species whose carbohydrate moiety was fully susceptible 
to Endo H digestion. In contrast, heavy chain mRNA trans- 
lated  in  the  presence of B2M  produced two closely spaced 
protein  bands,  of which  the  major  one  with  the  highest 
molecular weight was resistant to the  enzymatic treatment 
(Fig. 2, lanes C and D). A similar experiment, in which El9 
mRNA was substituted for the mRNA of the class I subunits, F~GURE  2  Influence of the E19 protein on the terminal glycosytation of class I antigens. Oocytes were microinjected with heavy 
chain mRNA alone (lanes A and B) and together with/5%M mRNA (lanes C and D). E19 mRNA was also used alone (lanes E and F) 
and together with heavy chain mRNA in the absence  (lanes G-l) and presence  of/~2M mRNA (lanes K-N).  After 26 h of [3ss]- 
methionine labeling, glycoprotein fractions were isolated  and immunoprecipitated with an anti-heavy chain serum  (lanes A-D 
and  G,  H,  K,  and  L)  and  with  an  anti-E19  monoclonal  antibody  (lanes  E,  F,  I,  J,  M,  and  N),  respectively.  Part of  each 
immunoprecipitate was treated with Endo H (lanes B, D, F, H, J, L, and N), while the remainder served as the control (lanes A, C, 
E, G, I, K, and M). mRNA present in the fraction enriched for/~2M  mRNA gave rise to the contaminants visualized in lanes C, D, 
K, and L (see reference 17). Figures denote apparent molecular weights in kilodaltons. 
revealed that the viral protein immunoprecipitated with an 
El9  monoclonal antiserum  was partly susceptible to  Endo 
H-induced carbohydrate elimination. Thus, Fig.  2  (lanes E 
and  F)  demonstrates that  after  enzymatic treatment,  El9 
resolved into three equally spaced electrophoretic bands. Al- 
though  the  pattern  of the  El9  bands  suggests  incomplete 
digestion,  a  fivefold increase of the  Endo  H  concentration 
produced results identical to those shown. 
These data are consistent with the notion that class I antigen 
heavy chains are transported to the trans--Golg~  compartment 
only if they are associated with B2M (l 5-17). However, since 
the  majority  of the  El9  molecules  were  sensitive  to  the 
enzyme  Endo  H,  these  observations  do  not  warrant  any 
definite conclusions about the putative transport of E 19 be- 
yond the cis-Gol# complex. 
The effect of the E 19 protein on the terminal glycosylation 
of the  class  I  antigens  was  examined  by injecting  various 
combinations of mRNA into oocytes, which were then proc- 
essed as described above. Co-translation of heavy chains and 
E 19 did not promote terminal glycosylation of the individual 
chains. This can be inferred from the observation that both 
heavy chains and E 19 were as susceptible to Endo H digestion 
as when translated individually (in  Fig.  2,  compare lanes A 
and B with G and H, and lanes E and F with I and J). Despite 
the fact that the particular antiserum used against the heavy 
chains did not co-precipitate noticeable amounts of the El9 
protein, the two types of molecules do indeed associate. This 
was  established  by  the  monoclonal  antibody  against  El9, 
which co-precipitated at least a  fraction of the heavy chains 
(see Fig. 2, lanes I and J). 
Also, when mRNA encoding ~2M was mixed with the E 19 
and  heavy chain  mRNA and injected into oocytes, the ter- 
minal glycosylation of the class I antigen heavy chains was 
inhibited. Fig.  2 (lanes K and L) demonstrates that virtually 
all immunoprecipitated heavy chains were sensitive to Endo 
H  digestion.  Likewise, Endo H  treatment of molecules im- 
munoprecipitated by the monoclonal antibody against E 19 
revealed a very similar if not identical electrophoretic pattern 
to that obtained when El9  was translated alone (in  Fig.  2, 
compare lanes E  and  F  with M  and  N).  The  monoclonal 
antibody  co-precipitated  small  amounts  of heavy  chains, 
whereas  the  anti-heavy  chain  serum  did  not  bring  down 
measurable amounts of the E 19 protein. Despite these weak 
to insignificant co-precipitations, it seems reasonable to con- 
clude that the class I antigens and the El 9 protein interacted. 
The experiments described above were repeated, but rather 
than  using  a  fraction  enriched  for  El9  mRNA,  we  used 
hybridization-selected  El9  mRNA.  Translation  of  this 
mRNA in oocytes gave rise to only one detectable product 
apart  from  the  endogeneous  proteins.  The  hybridization- 
selected mRNA alone and co-translated with mRNA encod- 
ing the class I antigen subunits generated results identical to 
those  depicted  in  Fig.  2.  The  translated  viral  protein  also 
displayed susceptibility towards Endo H  digestions identical 
to that shown in the figure.  These data unequivocally dem- 
onstrate that it is the E 19 protein and no other virus products 
that impedes the terminal glycosylation of the class I antigen 
heavy chains. 
Class I Antigen Heavy Chains Do Not Become 
Terminally Glycosylated  in Adenovirus-2-infected 
HeLa Cells 
To verify that the E 19 protein affects the terminal glycosyl- 
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HeLa cells were infected with adenovirus-2. Thus, mock- and 
virally infected cells were labeled with [3SS]methionine for 10 
min and then chased with an excess of unlabeled methionine 
for 2 h. Samples were withdrawn at the beginning and end of 
the  chase  period,  glycoproteins were  isolated,  and  class  I 
antigens  were  indirectly  immunoprecipitated.  Before  SDS 
PAGE analysis,  part of each sample was treated with Endo 
H. Fig.  3 summarizes the results.  It can be seen that at the 
beginning  of the  chase  period, the  majority of the  class  I 
antigen heavy chains were susceptible to the enzymatic treat- 
ment  regardless  of whether the  chains  were derived from 
mock (Fig.  3, lanes A and B) or virally (Fig.  3, lanes E  and 
F) infected cells. After 2 h of chase,  the heavy chains of the 
mock-infected cells were completely resistant to the Endo H 
digestion (Fig. 3, lane D) while at the same time in the virally 
infected cells, all heavy chains appeared to remain in the high 
mannose form as evidenced by their sensitivity to the enzyme 
(Fig. 3, lane H). The El9 protein, which co-precipitated with 
the class  I antigens, was virtually completely susceptible to 
the Endo H digestion at both times investigated. These data 
demonstrate that class I antigen heavy chains in an adenovi- 
rus-infected mammalian cell display abrogated terminal gly- 
cosylation in a way apparently identical to that encountered 
in the oocytes (see above). 
FIGURE  3  Effect  of the  E19  protein on the terminal glycosylation 
of class  I antigen heavy chains in adenovirus-2-infected HeLa cells. 
HeLa cells were mock-infected or infected with adenovirus-2 for 4 
h. Mock-infected  (lanes A-D) and infected  HeLa cells (lanes E-H) 
were labeled with  [3SS]methionine for  10 rain and either immedi- 
ately chilled to 0°C (lanes A, B,  E, and F) or chased for 2  h with an 
excess of unlabeled methionine (lanes C, D, G, and H) before being 
lysed.  Glycoprotein  fractions  were  immunoprecipitated  with  an 
anticlass I heavy chain serum. Before SDS PAGE, half of each sample 
was digested with  Endo  H  (lanes B,  D,  F, and  H).  Figures denote 
apparent molecular weights in kilodaltons. 
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Cell Surface Expression of Class I Antigens in the 
Presence and Absence of the El9 Protein 
The experiments described above do not rule out that the 
El 9 protein becomes transported beyond the cis-Golgi com- 
partment despite lack of evidence of terminal glycosylation 
of its carbohydrate moieties.  Likewise,  the experiments do 
not formally rule out that the E 19 protein impairs the terminal 
glycosylation of the  class  I  antigen  heavy chains  without 
affecting their intracellular transport. To examine these pos- 
sibilities,  we explored the cell surface expression of the two 
proteins. Consequently, oocytes were separately injected with 
mRNA encoding heavy chains, heavy chains and ~2M, heavy 
chains and ~2M and El9,  heavy chains and E19, and El9 
alone, respectively. After labeling with [3SS]methionine for 24 
h  and removal of visually damaged  oocytes, the cells were 
defolliculated and the cell surface expression of heavy chains 
and E 19 was examined as described in Materials and Methods. 
To  avoid  unnecessary dilution  of the  samples,  no  lectin- 
column chromatography step preceded the immunoprecipi- 
tations.  Fig.  4  summarizes the results.  While heavy chains 
were efficiently translated in the absence of ~2M (Fig. 4, lane 
H), they could, as expected, not be discovered on the oocyte 
cell surface (Fig. 4, lane A). This result ascertained that the 
adopted methodology  discriminated between intracellular and 
cell surface-expressed heavy chains. 
After translation in the presence of~2M, two distinct heavy 
chain species could be discerned on the cell surface (Fig. 4, 
lane B). In addition to the major core-glycosylated compo- 
nent, a  slightly  higher molecular weight form of the heavy 
chains was evident in the intracellular fraction (Fig.  4, lane 
I).  The small amounts of heavy chains in  the cell surface 
fraction may  have  represented contaminating  intracellular 
molecules, although it is known that the oocyte system may 
give poor cell-surface expression also of other proteins (see 
reference 24). To rule out the possibility of contamination, 
the experiment was  repeated. However, before SDS PAGE 
analysis, the immunoprecipitated heavy chains were subjected 
to Endo H  digestion. Whereas all  heavy chains in the cell 
surface fraction were unaffected by the enzymatic treatment, 
~40%  of the heavy chains in the intracellular fraction dis- 
played enhanced electrophoretic mobility upon Endo H diges- 
tion. Thus, these data make it unlikely that the heavy chains 
in the cell surface fraction were contaminants derived from 
the intracellular fraction. 
The E 19 protein was also efficiently translated in the oo- 
cytes (Fig. 4, lane J) but if present on the oocyte surface, it 
was below the level  of detection (Fig.  4,  lane C).  A conse- 
quence of these observations was that translation of mixtures 
of heavy chain and El9 mRNA did not promote measurable 
cell surface expression of either polypeptide (Fig. 4, lanes D 
and E). When the two class I antigen subunits were translated 
in the presence of E 19, neither heavy chains (Fig. 4, lane F) 
nor El9 (Fig. 4, lane G) could be detected at the cell surface. 
The heavy chains present in the intracellular fraction did not 
display the electrophoretically more slowly  migrating band 
that corresponds to terminally glycosylated molecules (com- 
pare lane I with lane M of Fig. 4). 
From these data,  it may be suggested  that in  contrast to 
class  I  antigens, the  El9  protein is  not transported to the 
occyte cell surface. Moreover, the E 19 protein seems to abol- 
ish the cell surface expression of the class I antigens. FIGURE  4  Abrogation of cell surface expression  of class I antigens  by the E19 protein. Oocytes were microinjected with heavy 
chain mRNA alone (lanes A and H) and together with fl2M  mRNA (lanes B and I). Separately, oocytes were injected with E19 
mRNA alone (lanes C and J) and together with heavy chain mRNA in the absence (lanes D, E, K, and L) and presence (lanes F, C, 
M, and N) of fl2M mRNA. After incubation with [3SS]methionine for 24 h, the oocytes were processed as described in Materials 
and Methods. In lanes A, B, D, F, H, I, K, and M the anti-heavy chain serum was used and in lanes C, E, G, J, L, and N an anti- 
E19  monoclonal antibody was used.  Lanes A-G  depict proteins located on the oocyte surface  and  lanes  H-N,  intracellular 
proteins.  Contaminating proteins  are  present  due  to  the  fact  that  no  enrichment of  glycoproteins on  the  Lens Culinaris 
hemagglutinin columns had been performed. In lanes C-G and J-N, a contaminating protein with an apparent molecular weight 
slightly greater than that of fl2M is evident. This component, which was precipitated by nonimmune serum, was derived from the 
E19 mRNA fraction since  it was absent when hybridization-selected E19 mRNA was used.  Figures denote apparent molecular 
weights in kilodaltons. 
Quantitative Aspects of the Interaction between 
El9 and Class I Antigens 
To gain further insight into the quantitative effects of fl2M 
and El9  on the intracellular processing of the heavy chain, 
oocytes were injected with constant amounts of mRNA en- 
coding heavy chains and increasing amounts of fl2M mRNA 
in the absence and presence of two different concentrations 
of E 19 mRNA. Glycoproteins were isolated from the microin- 
jected  and  [3~S]methionine-labeled  oocytes.  Heavy  chains 
were precipitated with an anti-heavy chain serum, and part 
of each immunoprecipitate was treated with Endo H  before 
analysis by SDS PAGE.  The relative amounts of Endo  H- 
resistant heavy chains,  expressed as the  percentage of total 
heavy chains precipitated,  were estimated by densitometry. 
Fig.  5 shows that on increasing the amounts of flEM mRNA 
injected, progressively more heavy chains became resistant to 
the enzymatic treatment. In the presence of low amounts of 
E 19 mRNA, fl2M also promoted the generation of terminally 
glycosylated heavy chains, but the effect was considerably less 
pronounced than in the absence of  the virus protein. At higher 
concentrations  of the  viral mRNA,  B2M  could  not  confer 
Endo H resistance to the heavy chains (Fig. 5). 
In a similar set of experiments, constant amounts ofmRNA 
encoding class I antigen heavy chains and fl2M were mixed 
with  various amounts of El9  mRNA before injection  into 
oocytes.  Giycoproteins,  labeled  with  [35S]methionine,  were 
immunoprecipitated  with  antibodies  reactive  with  heavy 
chains, and part of each immunoprecipitate was treated with 
Endo H. The amount of fl2M mRNA used in these experi- 
ments was sufficient to ascertain that approximately half of 
the heavy chains became terminally glycosylated. When trans- 
lated in the presence of increasing amounts of El 9 mRNA, 
the fraction of Endo H-resistant heavy chains progressively 
decreased (Fig. 6). These data show that fl2M and El9 have 
opposite effects on the terminal glycosylation of  class I antigen 
heavy chains. It is also obvious that heavy chains associated 
with fl2M exhibit abolished terminal glycosylation if the con- 
centration of E 19 is sufficiently high. 
DISCUSSION 
The interaction between E 19 and class I transplantation an- 
tigens has hitherto been examined mainly in an adenovirus- 
transformed rat fibroblast cell line (5, 7). These cells produce 
considerably less  E19  protein than  do  acutely adenovirus- 
infected human cells.  Since the noncovalent interaction be- 
tween the viral protein and the class I antigens is concentration 
dependent,  we  have  explored  the  intracellular  interaction 
between the two proteins by microinjecting purified mRNA 
fractions into oocytes. This experimental system provides the 
possibility to vary the concentrations of the mRNA encoding 
the various polypeptides. Moreover, the phenotypic changes 
induced  by infection and  transformation, which  may indi- 
rectly affect the binding and intracellular behavior of class I 
antigens and El9, are avoided in the oocyte system. 
The intracellular transport of class I antigen heavy chains 
in Xenopus laevis oocytes is regulated by fl2M (17)  as is the 
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FIGURE  5  Effect of increasing amounts of/~2M  mRNA on the ter- 
minal glycosylation of heavy chains in the absence and presence of 
E19. The  fraction enriched  for  heavy  chain  mRNA was microin- 
jected into oocytes together with increasing amounts of the fraction 
enriched for/5'2M mRNA alone or together with two concentrations 
of the fraction enriched for E19 mRNA. Glycoproteins were isolated 
from oocytes labeled with [35S]methionine for 24 h, and immuno- 
precipitated with an anti-heavy chain serum.  Part of each immu- 
noprecipitate was treated with  Endo  H  before analysis  by  SDS 
PAGE. The relative amounts of the heavy chains were determined 
by densitometric analysis. The percentage of heavy chains resistant 
to the enzymatic treatment out of the total amount of heavy chains 
(Endo H sensitive and resistant chains) was calculated for each/~2M 
mRNA  concentration  in  the  absence and  presence  of  the  E19 
protein. The amounts of/~2M translated were proportional to the 
amounts of injected mRNA  and  are expressed  in  arbitrary units 
(A.U.). The symbols denote no E19 mRNA ((3), 0.03 p,g/#l of mRNA 
(A), and 0.06 p,g/#l of mRNA enriched for E19 mRNA (A), respec- 
tively. 
case in mammalian cells (15,  16). This was confirmed in the 
present study, and we could show that in the presence of ~2M, 
the heavy chains became not only terminally glycosylated but 
also expressed on the oocyte surface. It seems unlikely that 
this  observation  was  due  to  fortuitous  contamination  by 
intracellular  material,  since  free heavy chains,  which  were 
present intracellularly,  could  not  be discovered on the  cell 
surface and in the presence of ~2M; only terminally glycosy- 
lated heavy chains could be detected in the cell surface frac- 
tion. The E 19 protein was efficiently translated by the oocytes, 
but  we  failed to  show  its  presence  on  the  cell  surface.  In 
keeping with this negative finding, the El9 protein was sus- 
ceptible  to  Endo  H  digestion  throughout  the  pulse-chase 
period. 
These observations do not  formally rule  out  that  minor 
amounts of El9,  too small to detect with the methodology 
employed,  may have appeared on  the  oocyte cell  surface. 
However,  El9  and  class  I  antigens  in  adenovirus-infected 
HeLa cells  also  fail  to  become terminally glycosylated, as 
shown in the present study. In fact, the nascent chains do not 
become integrated into the plasma membrane and as the virus 
infection progresses, the cells display gradually diminishing 
quantities of cell  surface-expressed class I antigens (Anders- 
son, M., S. P~i~ibo, T. Niisson, and P. A. Peterson, manuscript 
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submitted for publication). Thus, it seems reasonable to con- 
clude  that  the  impaired  terminal  glycosylation  of class  I 
antigens translated  together with  E19  in  oocytes is due  to 
abrogated intracellular transport as is the case in virally in- 
fected cells. 
The Endo H digestion always gave rise to three electropho- 
relic species of the El9 protein. These results are consistent 
with incomplete Endo H  digestion of two Asn-linked carbo- 
hydrate moieties (13).  However, increased concentrations of 
the enzyme did not promote additional digestion. Since Endo 
H  does not cleave terminally glycosylated or fully trimmed 
carbohydrate moieties (27),  it may be argued that a fraction 
of the El9  molecules had undergone one or both of these 
carbohydrate modifications. That E 19 undergoes trimming is 
obvious from the pulse-chase experiments. However, it is less 
obvious whether the trimming involves mannose residues in 
the cis-Golgi compartment as well as glucose residues in the 
endoplasmic reticulum (28). The trimming seems to be facil- 
itated when El9 is translated in the presence of class I anti- 
gens, but the resistance of El9 to Endo  H  digestion is not 
measurably  altered  under  these  circumstances.  Moreover, 
heavy chains, co-precipitated with El 9, are fully susceptible 
to the glycosidase.  Therefore, it seems reasonable to suggest 
that the trimming is confined to the endoplasmic reticulum. 
If so, the partial resistance of El9 to the action of Endo H 
remains obscure. 
The association between E 19 and the class I antigens was 
recorded by immunological co-precipitations only. The non- 
covalent interaction is concentration-dependent and may be 
perturbed by antibodies (7). This observation renders immu- 
nological co-precipitations difficult to interpret in quantitative 
terms. Thus, in the present study, the antibodies used against 
El9 co-precipitated class I antigen heavy chains when large 
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FIGURE  6  Effect  of  varying amounts of  the  E19  mRNA  on  the 
terminal glycosylation of  heavy chains  in  the  presence of /~2M. 
Oocytes were microinjected with constant amounts of heavy chain 
and  /32M mRNA  together with varying amounts of  E19  mRNA. 
Glycoprotein fractions  isolated from  oocytes  labeled with  [3sS]- 
methionine  for  24  h  were  immunoprecipitated with  antiserum 
against heavy chains.  Part of each immunoprecipitate was treated 
with  Endo  H  before analysis  by  SDS  PAGE. Fluorographs  were 
subjected to densitometric analysis and the percentage of heavy 
chains  resistant to  Endo  H  treatment out of the total amount of 
heavy chains  precipitated (Endo  H  sensitive  and  resistant  heavy 
chains),  was calculated for  each  E19  mRNA  concentration. The 
amounts of the E19  protein translated were proportional to the 
amount of  mRNA  injected  and  are expressed  in  arbitrary units 
(A.U.). amounts of El9 were produced (see Fig.  2), whereas little or 
no co-precipitation could be visualized at lower concentra- 
tions of the virus protein (Figs. 1 and 4). In contrast, antibod- 
ies against class I antigens generally failed to co-precipitate 
the viral protein in the oocytes, while substantial amounts of 
co-precipitated E 19 were encountered in virally infected HeLa 
cells  (Fig.  3).  Studies  aimed  at  elucidating  the  particular 
features of the complex formation between the two types of 
proteins obviously will require the development of improved 
techniques to monitor the association. Nonetheless, the pres- 
ent study confirms the finding that the viral protein associates 
with class I antigens and  demonstrates that the interaction 
occurs intracellularly. 
The effect of E 19 on the terminal glycosylation of class I 
antigen heavy chains combined with ~M  is concentration 
dependent. At relatively high concentrations orE 19, the trans- 
fer of the heavy chains to the trans-Golgi compartment seems 
to be impeded. Thus, the heavy chains behave as if no ~2M 
were present inasmuch as they are fully sensitive to Endo H 
digestion. Likewise, the 82M-promoted cell surface expression 
of the heavy chains is  abolished.  At  low concentrations of 
E 19, #2M partly overcomes the effect of the viral protein, and 
terminal glycosylation of heavy chains occurs.  Although  it 
cannot be ruled out that El9  may affect trimming enzymes 
and/or  glycosyl  transferases  to  account  for  the  abolished 
terminal glycosylation, it also must impede the intracellular 
transport of the class I  antigens.  It is  conceivable that  the 
mere  association between  the  viral  protein  and  the  heavy 
chains suffices  to  abrogate  the  intracellular transport.  The 
apparently contrasting effects of ~2M  and E 19 on the intra- 
cellular transport of the heavy chain may then be explained 
on  the  assumption that  heavy chains,  upon  binding  82M, 
attain  a  conformation that exhibits diminished  affinity for 
E 19. Alternatively, the structural homology between El9 and 
/~2M (29) may suggest that the two proteins compete for the 
same binding site on the heavy chain. However, apart from 
the homology being weak at best,/~2M-associated heavy chains 
in the presence of El9 do not become terminally glycosylated. 
Previous studies in transformed and infected mammalian 
cells have demonstrated the existence of class I antigen-E 19 
complexes and have shown that E 19 becomes degraded in a 
compartment sensitive  to  lysosomotropic agents  (30).  The 
present study suggests that in oocytes, complex formation is 
initiated  intracellularly  and  is  accompanied  by  abrogated 
intracellular transport of the class I antigens. Similar results 
were recorded in adenovirus-infected HeLa cells as reported 
here and in more detail elsewhere (Andersson, M., S. P~i~ibo, 
T.  Nilsson,  and  P.  A.  Peterson,  manuscript submitted  for 
publication). These observations raise the intriguing possibil- 
ity that adenovirus-2 may use E 19 to escape immune surveil- 
lance. 
Interestingly, the adenovirus-2 genome does not possess the 
same type of Ela region as does adenovirus-12, whose Ela 
impedes the transcription of class I antigen heavy chain genes 
(31,  32).  Thus,  two  viruses of the  same  family  may  have 
developed different strategies to avoid the same defense mech- 
anism of the host. 
We are grateful to Svante P~bo for the kind gift of the cloned EcoRI- 
D  fragment of adenovirus-2 and to Mats Andersson and Carmen 
Fernandez for the kind gift of the El9  monoclonal antibody. All 
other colleagues are acknowledged for valuable help and discussions. 
Excellent assistance in preparing this manuscript was provided by 
Ms. C. Pl6en. 
This study was supported by  grants from the Swedish Cancer 
Society and the Swedish Natural Research Council. 
Received for publication  27December1984,  and  in  revised form 
17 April 1985~ 
REFERENCES 
I.  Klein,  J.. editor.  1975. Biology  of the Mouse Hislocompatibility-2-complex.  Springer 
Verlag. New York. 620 pp. 
2.  Zinkernagel. R.  M., and P. C. Doherty.  1974. Restriction  of in vitro T-cell  mediated 
cylotoxicity  in  lymphocytic choriomeningitis within  a  syngeneic or semi allogeneic 
system. Nature (Lond.).  248:701-702. 
3.  Peterson,  P. A., and O. Kfimpe. 1981. Are the classic transplantation antigens primitive 
cell  surface  antibodies?  In Current  Trends  in  Histocompatibility.  Volume  1.  R.  A. 
Reisfeld and S. Ferrone,  editors.  Plenum Publishing Corp., New York. 437-455. 
4.  P~bo, S., O. K~mpe, L. Scverinsson,  M. Andersson, C. Fernandez, and P. A. Peterson. 
1984.  The  association  between  class I  transplantation  antigens and  an  adenovims 
membrane protein.  Prog. Allergy. 36:114-134. 
5.  Kvist, S., L. Ostberg, H. Persson,  L. Philipsson,  and P. A. Peterson.  I978. Molecular 
association  between transplantation antigens and a cell surface antigen in an adenovirus- 
transformed cell line. Proc. NatL Acad. Sci.  USA. 75:5674-5678. 
6.  Sign,s, C., M. G. Katze, H. Persson, and L. Philipsson.  1982. An adenovirus glycoprotein 
binds heavy chain of class I transplantation  antigens from man and  mouse.  Nature 
(Lond.).  299:175-178. 
7.  Y-drape, O.. D. Bellgrau,  U. Hammerling, P. Lind, S. P~5.bo, L. Severinsson,  and P. A. 
Peterson.  1982.  Complex  formation  of class  I  transplantation  antigens and  a  vital 
glyeoprotein.  Z  Biol. Chem. 258:10594-10598. 
8.  P~bo, S., F. Weber, O. l~mpe, W. Sehaffner,  and P. A. Peterson.  1982. Association 
between transplantation  antigens and a  viral membrane protein  synthesized  from a 
mammalian expression vector.  Cell. 35:445--453. 
9.  Ross, S., and A. J. Levine. 1979. The genomic map position  of the adenovirus type 2 
glyeoprotein.  Virology. 99:427--430. 
10.  Persson, H., M. Jansson, and L. Phifipsson.  1980. Synthesis  and genomic site for an 
adenovirns type 2 early glycoprotein.  J. Mol. Biol.  136:375-394. 
11.  Storeh,  T. G., and J. V. Maizel,  Jr. 1980. The early  proteins of the nondefeetive Ad2- 
SV40 hybrid viruses: the  19K glycoprotein  is coded by Ad-2 eady region 3.  Virology. 
103:5467. 
12.  Herisse,  J., G. Courtois, and F. Galivert. 1980. Nucleotide sequence  of the Eeo RID 
fragment of adenovirus 2-genome. NudeicAcids Res. 8:2173-2192. 
13.  Kornfeld,  R.,  and  W.  S.  M.  Wold.  1981. Structure  of the oligo-saceharides  of the 
glycoprotcin  coded by early region E3 of adenovirns-2. J. Virol. 40:440--449. 
14.  Dobberstein,  B.,  H. Garoff, and G. Warren.  1979. Cell-free  synthesis  and membrane 
insertion  of  mouse  H-2D  a  histocompatibility  antigen  and  B2-micrnglobulin.  Cell. 
17:759-769. 
15.  Owen, J. O., A.-M.  Kissonerghis, and H. F. Lodish.  1980. Biosynthesis  of HLA-A and 
HLA-B antigens in vivo. J. Biol. Chem.  255:9678-9684. 
16.  Sege, K., L. Rask, and P. A. Pcterson.  1981. Role of #2-microglobulin  in the intracellular 
processing of HLA antigens. Biochemistry.  20:4523--4530. 
17.  Scverinsson,  L., and P. A. Pcterson.  1984. B2-Miernglobulin  induces intracellular  trans- 
port of human class I transplantation  antigen heavy chains in Xenopus laevis oocytes. 
J. Cell Biol. 99:226--232. 
18.  Rask, L.,  J.  B. Lindblom,  and  P. A. Pcterson.  1976. Structural  and immunological 
similarities between HLA antigens from three loci. Eur. J. lmmunol. 6:93-100. 
19.  Kvist, S., K. Wiman, L. Claesson,  P. A. Peterson, and B. Dohberstein.  1982. Membrane 
insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell. 29:61- 
69. 
20.  Wiman, K., D. Larhammar, L. Claesson,  K. Gustafsson, L. Schenning,  P. Bill, J. B6hme, 
M. Denato, B. Dobberstein,  U. Hammerling, S. Kvist, B. Servenius,  J. Sundelin,  P. A. 
Peterson,  and L. Rask. 1982. Isolation and identification  of  a eDNA clone corresponding 
to an HLA-DR antigen # chain. Proc. Natl. Acad Sci.  USA. 79:1703-1707. 
21.  Ricciardi, R. P., J. S. Mifler,  and B. W. Roberts.  1979.  Purification and mapping of 
specific  mRNAs by hybridization selection  and cell-free translation.  Proc.  Natl. Acad 
Sci. USA. 76:4927--4931. 
22.  Gurdon, J. B.  1976. Injected nuclei in frog oocytes:  fate, enlargement and chromatin 
dispersal. J. Embr~l. Exp. Morphol. 36:523-540. 
23.  Hayman,  M.  J.,  and  M.  J.  Crumpton.  1972. Isolation  of glycoproteins  from  pig 
lymphocyte  plasma  membrane  using Lens Culinaris  phytohemagglutinin.  Biochem. 
Biophys. Res. Commun. 47:923-930. 
24.  Huth, A., T. A. Rapaporl, and L. K~i~ri~iinen. 1984. Envelope  proteins of Semliki Forest 
virus synthesized  in Xenopus oocytes are transported to the cell surface.  EMBO (Eur. 
Mol. Biol. Organ.)J. 4:767-771. 
25.  Blobel. G, and B. Dobberstein. 1975. Transfer of proteins across membranes. I. Presence 
of proteolytically  processed  and unprocessed  nascent immunnglobulin light chains on 
membrane-bound ribosomes of murine myeloma. J. Ce/I Biol. 67:835-85 I. 
26.  Bonner,  W. M.. and R. A. Laskey.  1974. A film detection method for tritium-labelled 
proteins and nucleic  acids in polyacrylamide gels. Eur J. Biochem.  46:83-88. 
27.  Tarentino.  A.  L.,  and  F.  Maley.  1974. Purification and  properties  of an Endo-~-N- 
acetylglucosaminidase  from Streptomyces  griseus, J. BioL Chem.  249:811-817. 
28.  Wagh, P. V., and O. P, Bahl.  1981. Sugar residues on proteins CRC. Crit. Rev. Biochem. 
I 1:307-377. 
29.  Chatterjee.  D., J. V. Maizel,  Jr.  t984.  Homology of adenoviral E3  glycoprotein  with 
HLA-DR heavy chain.  Proc. Natl. Acad. Sci. USA. 81:6039-6043. 
30.  Kampe, O., D. Larhammar, K. Wiman, L. Schenning,  L. Claesson,  K. Gustafsson, S. 
P~iabo, J. J. Hyldig-Nielsen,  L. Rask, and P. A. Peterson.  1983. Molecular  analysis of 
MHC antigens.  In Genetics of the Immune Response.  E. M611er and G. Moiler,  editors. 
Plenum Publishiog Corp., New York. 61-87. 
31.  Schrier,  P. L., R. Bernards,  R. T. M. J. Vaessen,  A. Honweling, and A. J. van tier Eb. 
1983.  Expresston  of class  I  major hislocompatibility antigens switched off by highly 
oncogenie adenovirus 12 in transformed rat cells. Nature (Land.).  305:771-775. 
32.  Beruhards,  R., P. L  Schrier,  A. Houweling, L L. Bo~, A. J. van tier Eb, M. Zijlstrasmd, 
and C. J. M. Melief.  1983. Tumorigenicity of cells transformed by adenovirus type 12 
by evasion of T-cell immunity. Nature (Lond.).  305:776-779. 
SEVERINSSON AND  PETERSON  E  [ 9 Inhibits Transport of Class I Antigens  547 